Skip to main content
Equibles

FMS · Fresenius Medical Care AG · Earnings Call Transcripts & Audio

Track FMS — free

Use FMS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FMS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$22.35 +0.12 (+0.54%) At close · Sep 11
Rebalance outlook locked
Market Cap
$11.90B
Shares
532.22M

Fresenius Medical Care AG Earnings Call Transcripts

Quarterly earnings calls for Fresenius Medical Care AG (FMS), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Earnings call
FY26 · Q3
2026-11-03
Fresenius Medical Care AG (FMS) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-04
Fresenius Medical Care AG (FMS) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-05
Fresenius Medical Care AG (FMS) Q1 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Fresenius Medical Care AG (FMS) Q4 2025 Earnings Call Transcript
Confident tone TDAPA and phosphate binders contribution U.S. Care Delivery volumes and missed treatments FME25+ transformation and savings program
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript
Positive tone Care delivery volume and treatment growth FME Reignite strategy and capital allocation High-volume HDF rollout and 5008X machine
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript
Positive tone Care Enablement segment performance Value-Based Care segment U.S. patient volume and flu impact
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Fresenius Medical Care AG (FMS) Q1 2025 Earnings Call Transcript
Confident tone Care Enablement Margin Expansion Care Delivery Earnings & Phosphate Binders U.S. Same Market Treatment Growth & Referrals
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Fresenius Medical Care AG (FMS) Q4 2024 Earnings Call Transcript
Confident tone Care Delivery and Care Enablement margins FME25 transformation and cost program U.S. same market treatment growth and volumes
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Fresenius Medical Care AG (FMS) Q3 2024 Earnings Call Transcript
Positive tone U.S. same market treatment growth Care Enablement and China VBP Operational performance and margin progress
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Fresenius Medical Care AG (FMS) Q2 2024 Earnings Call Transcript
Positive tone Care Delivery volumes and same market treatment growth Mortality and flu/COVID impact FME25 transformation and cost savings
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Fresenius Medical Care AG (FMS) Q1 2024 Earnings Call Transcript
Positive tone FME25 transformation program Care Enablement margin inflection Care Delivery transformation
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Fresenius Medical Care AG (FMS) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Fresenius Medical Care AG (FMS) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Fresenius Medical Care AG (FMS) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Fresenius Medical Care AG (FMS) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Fresenius Medical Care AG (FMS) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Fresenius Medical Care AG (FMS) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Fresenius Medical Care AG (FMS) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Fresenius Medical Care AG (FMS) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Fresenius Medical Care AG (FMS) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Fresenius Medical Care AG (FMS) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Fresenius Medical Care AG (FMS) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2020-06-30
Fresenius Medical Care AG (FMS) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Fresenius Medical Care AG (FMS) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1333141 CUSIP 358029106 13F (30d) 50 filings 49 filers Visit website Investor relations